| A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering J Zhu, N Ananthaswamy, S Jain, H Batra, WC Tang, DA Lewry, ... Science advances 7 (37), eabh1547, 2021 | 47 | 2021 |
| The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop … N Ananthaswamy, R Rutledge, ZE Sauna, SV Ambudkar, E Dine, ... Biochemistry 49 (21), 4440-4449, 2010 | 47 | 2010 |
| The deviant ATP-binding site of the multidrug efflux pump Pdr5 plays an active role in the transport cycle C Furman, J Mehla, N Ananthaswamy, N Arya, B Kulesh, I Kovach, ... Journal of Biological Chemistry 288 (42), 30420-30431, 2013 | 44 | 2013 |
| A new approach to produce HIV-1 envelope trimers: both cleavage and proper glycosylation are essential to generate authentic trimers W AlSalmi, M Mahalingam, N Ananthaswamy, C Hamlin, D Flores, G Gao, ... Journal of Biological Chemistry 290 (32), 19780-19795, 2015 | 36 | 2015 |
| The transmission interface of the Saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in drug resistance MT Downes, J Mehla, N Ananthaswamy, A Wakschlag, M Lamonde, ... Antimicrobial agents and chemotherapy 57 (2), 1025-1034, 2013 | 36 | 2013 |
| Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin S Chand, EL Messina, W AlSalmi, N Ananthaswamy, G Gao, G Uritskiy, ... Virology 508, 199-212, 2017 | 22 | 2017 |
| A bacteriophage-based, highly efficacious, needle-and adjuvant-free, mucosal COVID-19 vaccine J Zhu, S Jain, J Sha, H Batra, N Ananthaswamy, PB Kilgore, EK Hendrix, ... MBio 13 (4), e01822-22, 2022 | 21 | 2022 |
| A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer N Ananthaswamy, Q Fang, W AlSalmi, S Jain, Z Chen, T Klose, Y Sun, ... Nature communications 10 (1), 873, 2019 | 19 | 2019 |
| Design of bacteriophage T4-based artificial viral vectors for human genome remodeling J Zhu, H Batra, N Ananthaswamy, M Mahalingam, P Tao, X Wu, W Guo, ... Nature Communications 14 (1), 2928, 2023 | 8 | 2023 |
| CRISPR engineering of bacteriophage T4 to design vaccines against SARS-CoV-2 and emerging pathogens J Zhu, N Ananthaswamy, S Jain, H Batra, WC Tang, VB Rao Vaccine Design: Methods and Protocols, Volume 1. Vaccines for Human Diseases …, 2022 | 8 | 2022 |
| Function of a viral genome packaging motor from bacteriophage T4 is insensitive to DNA sequence Y Mo, N Keller, D delToro, N Ananthaswamy, SC Harvey, VB Rao, ... Nucleic acids research 48 (20), 11602-11614, 2020 | 3 | 2020 |
| Composition and methods of mrna vaccines against novel coronavirus infection Neeti ANANTHASWAMY, Yong-Sik Bong, David Brown, Renxiang Chen, Ju Hyeong ... WO Patent WO2023018831A2, 2023 | | 2023 |
| Function of a viral genome packaging motor from bacteriophage T4 is insensitive to DNA sequence DE Smith, Y Mo, N Keller, N Ananthaswamy, SC Harvey, VB Rao Biophysical Journal 120 (3), 36a, 2021 | | 2021 |
| Characterization of Transmitted/Founder CRF01_AE Virus Envelope Trimers from the RV217-early Capture HIV Cohort Study N Ananthaswamy, W Alsalmi, M Mahalingam, E Messina, S Chand, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 96-96, 2016 | | 2016 |
| Deciphering the Interaction between the V1V2 domain of HIV-1 envelop protein gp120 & α4β7 integrin of the host cell E Messina, S Chand, W AlSalmi, G Gao, Q You, G Uritskiy, M Mahalingam, ... Journal of International AIDS Society 18, 285-285, 2015 | | 2015 |
| Production and characterization of HIV-1 envelope trimers W AlSalmi, M Mahalingam, N Ananthaswamy, C Hamlin, D Flores, G Gao, ... | | 2015 |
| Genetic and Biochemical Characterization of the Signaling Interface and the Deviant ATP Binding Site in the Yeast Multidrug Transporter Pdr5 N Ananthaswamy Catholic University of America, 2012 | | 2012 |
